Search research articles
Contact Us
Filters
Showing results (161-170 of 174) with videos related to
Page
of 18
Sort By:
Journal of Clinical and Experimental Hematopathology : JCEH
|
February 9, 2018
Clinical management and outcomes of completely resected stage I follicular lymphoma
Akihiko Yokohama, Yoko Hashimoto, Makiko Takizawa, et al.
The American Journal of Surgical Pathology
|
October 12, 2020
CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors
Sumihito Nobusawa, Satoshi Nakata, Yoshiko Nakano, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
December 27, 2013
Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases
Yoko Hashimoto, Akihiko Yokohama, Akio Saitoh, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 14, 2012
[Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]
Yoko Hashimoto, Akihiko Yokohama, Akio Saitoh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 13, 2019
Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation
Yoshiko Nakano, Daiichiro Hasegawa, Douglas R Stewart, et al.
Acta Neuropathologica Communications
|
September 25, 2023
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
Kohei Fukuoka, Jun Kurihara, Tomoko Shofuda, et al.
Journal of Neuropathology and Experimental Neurology
|
November 29, 2020
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma
Manabu Natsumeda, Hiroaki Miyahara, Junichi Yoshimura, et al.
Molecular and Cellular Biology
|
June 22, 2002
Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice
Misako Haraguchi, Hiroaki Tsujimoto, Masakazu Fukushima, et al.
Brain Pathology (Zurich, Switzerland)
|
February 12, 2021
Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma
Ran Tomomasa, Yasuhito Arai, Reika Kawabata-Iwakawa, et al.
The American Journal of Surgical Pathology
|
March 13, 2026
BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 Fusion
Haruna Okuno, Takuma Nakashima, Yasuhito Arai, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 174) with videos related to
Sort By:
Page
of 18
Journal of Clinical and Experimental Hematopathology : JCEH
|
February 9, 2018
Clinical management and outcomes of completely resected stage I follicular lymphoma
Akihiko Yokohama, Yoko Hashimoto, Makiko Takizawa, et al.
The American Journal of Surgical Pathology
|
October 12, 2020
CNS Low-grade Diffusely Infiltrative Tumors With INI1 Deficiency, Possessing a High Propensity to Progress to Secondary INI1-deficient Rhabdoid Tumors
Sumihito Nobusawa, Satoshi Nakata, Yoshiko Nakano, et al.
Journal of Clinical and Experimental Hematopathology : JCEH
|
December 27, 2013
Prognostic importance of the soluble form of IL-2 receptorα (sIL-2Rα) and its relationship with surface expression of IL-2Rα (CD25) of lymphoma cells in diffuse large B-cell lymphoma treated with CHOP-like regimen with or without rituximab: a retrospective analysis of 338 cases
Yoko Hashimoto, Akihiko Yokohama, Akio Saitoh, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology
|
April 14, 2012
[Retrospective survey on the clinical features of non-Hodgkin lymphomas in Gunma Prefecture, Japan]
Yoko Hashimoto, Akihiko Yokohama, Akio Saitoh, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 13, 2019
Presacral malignant teratoid neoplasm in association with pathogenic DICER1 variation
Yoshiko Nakano, Daiichiro Hasegawa, Douglas R Stewart, et al.
Acta Neuropathologica Communications
|
September 25, 2023
Subtyping of Group 3/4 medulloblastoma as a potential prognostic biomarker among patients treated with reduced dose of craniospinal irradiation: a Japanese Pediatric Molecular Neuro-Oncology Group study
Kohei Fukuoka, Jun Kurihara, Tomoko Shofuda, et al.
Journal of Neuropathology and Experimental Neurology
|
November 29, 2020
GLI3 Is Associated With Neuronal Differentiation in SHH-Activated and WNT-Activated Medulloblastoma
Manabu Natsumeda, Hiroaki Miyahara, Junichi Yoshimura, et al.
Molecular and Cellular Biology
|
June 22, 2002
Targeted deletion of both thymidine phosphorylase and uridine phosphorylase and consequent disorders in mice
Misako Haraguchi, Hiroaki Tsujimoto, Masakazu Fukushima, et al.
Brain Pathology (Zurich, Switzerland)
|
February 12, 2021
Ependymoma-like tumor with mesenchymal differentiation harboring C11orf95-NCOA1/2 or -RELA fusion: A hitherto unclassified tumor related to ependymoma
Ran Tomomasa, Yasuhito Arai, Reika Kawabata-Iwakawa, et al.
The American Journal of Surgical Pathology
|
March 13, 2026
BEND2 Immunohistochemistry as a Useful Diagnostic Marker for Astroblastomas With BEND2 Fusion
Haruna Okuno, Takuma Nakashima, Yasuhito Arai, et al.
Page
of 18